1. Conceptual difference: Clinical pharmacy is a discipline that studies the rationality and effectiveness of drug prevention and treatment, and pharmacy is a health care industry that studies health science and chemical science;

2. Differences in employment direction: Clinical pharmacy is engaged in drug circulation, monitoring and identification in medical units at all levels, and pharmaceutical graduates are engaged in drug development, research and production in pharmaceutical factories or pharmaceutical research institutes.

Introduction to clinical pharmacy:

Clinical pharmacy refers to a discipline separated from hospital pharmacy. It is a comprehensive applied technical discipline which takes patients as the object, aims at improving the quality of clinical medication, focuses on the interaction between drugs and the body, and studies and practices the rational clinical application of drugs.

Western developed countries put forward the concept of "clinical pharmacy" in the middle and late 1950s, set up "clinical pharmacy specialty" in universities and established "clinical pharmacist system" in hospitals in the early 1960s. Pharmacists directly participate in clinical medication, which improves the level of clinical medication and protects the safety of patients.

Since the establishment of the clinical pharmacist system was first proposed in the Interim Provisions on the Administration of Pharmaceutical Affairs in Medical Institutions in 2002, in June 2006, the Ministry of Education decided to set up the clinical pharmacy specialty in the pharmacy specialty of colleges and universities, and the Ministry of Health took a series of measures.

For example, formulating clinical pharmacist training guidelines, establishing clinical pharmacist training bases and starting clinical pharmacist training pilots have effectively promoted the development of clinical pharmacy in hospitals.

Clinical pharmacy was first proposed and founded by the United States in the middle and late 1950s. At that time, the pharmaceutical industry in the United States was relatively developed and a large number of new drugs were developed and produced. With the increase of clinical drug use, irrational drug use is becoming more and more serious, and side effects and allergic reactions continue to occur.

At that time, the medical community's understanding of adverse drug reactions (ADR) was still superficial, and ADR monitoring was not established, so patients were often harmed by ADR.

This has attracted the attention of health administrative departments and medical and health circles, and put forward requirements for pharmaceutical professionals to strengthen prescription review, participate in clinical medication, promote rational drug use, prevent adverse reactions and improve the quality of drug treatment.